IngredientsThe term globulin does not refer to a single compound but to a large and functionally diverse superfamily of proteins unified primarily by their solubility properties. In biochemical classification, globulins are proteins that are insoluble in pure water but soluble in dilute salt solutions, a property that distinguishes them from albumins (water-soluble) and prolamins (ethanol-soluble). According to Osborne's classification, storage proteins are divided into globulins, albumins, glutelins, and prolamins; globulins are extracted in salt solutions, albumins are soluble in water, glutelins are soluble in acids or bases, and prolamins are soluble in ethanol.
As a dietary supplement and nutritional ingredient, the term "globulins" spans three distinct contexts: (1) serum globulins — proteins naturally present in blood plasma that perform carrier, enzymatic, and immune functions; (2) animal-derived immunoglobulins (gamma globulins) — antibody proteins isolated from bovine serum or colostrum and consumed orally; and (3) plant seed globulins — storage proteins predominantly of the 7S (vicilin) and 11S (legumin) families found in legumes, seeds, and cereals that serve as the main protein fraction in plant-based protein supplements. This article addresses all three contexts in detail.
Globulins are a group of proteins within the blood that include immunoglobulins, enzymes, carrier proteins, and complement proteins. Three types of globulin have been identified — alpha, beta, and gamma. Alpha and beta globulins are transport proteins, serve as substrates upon which other substances are formed, and perform other diverse functions. Gamma globulins have a vital role in natural and acquired immunity to infection.
Alpha and beta globulin are produced in the liver and gamma globulin is synthesized in lymphoid tissues. Globulins are further classified into alpha (α)-, beta (β)-, and gamma (γ)-fractions. Most acute phase proteins are either α- or β-globulins, and, depending on the inflammatory process and type of globulin, variable increase and decrease of certain globulins may aid diagnosis of disease, response to therapy, and prognosis. The γ-globulin fraction contains the immunoglobulins of which IgG, IgM, IgE, and IgA are measurable in serum.
Specific alpha-globulin proteins of physiological importance include alpha-1 antitrypsin and alpha-2 macroglobulin; prominent beta-globulins include transferrin, haptoglobin, and low-density lipoprotein (LDL); and the gamma-globulin fraction is composed principally of immunoglobulins of the IgG, IgA, IgM, and IgE classes.
The most commercially relevant animal-derived globulin used in dietary supplementation is serum-derived bovine immunoglobulin/protein isolate (SBI), also referred to as bovine immunoglobulin concentrate or immune globulin bovine. The SBI contains high concentrations of immunoglobulins, with >50% immunoglobulin (Ig)G, 1% IgA, and 5% IgM that can be taken orally. This product is manufactured from bovine blood serum through fractionation processes and is distinct from colostrum-derived immunoglobulins, though both are used as oral supplements.
Bovine colostrum is a closely related source. Secretory IgA is found in particularly high concentrations in colostrum. Colostrum is milk produced by mammals over a period extending from shortly before to shortly after giving birth. Colostrum contains on average 300 mg/dL secretory IgA, compared with 50 mg/dL for mature milk.
Globulins are the major seed storage proteins of spermatophytes. Vicilins (7S globulins) and legumins (12S globulins) form the two major classes of globulins. Globulins are predominant in legume seeds, while prolamins and glutelins are prominent in cereal seeds. Legumin, vicilin, and convicilin are the globulins present in legumes.
According to their sedimentation coefficient, globulins are divided into 7S and 11S oligomeric proteins. The 7S proteins are called vicilins; the 11S proteins are named legumins. Biochemically, vicilin assembles as a trimeric glycoprotein with an overall molecular weight of approximately 150–190 kDa, composed of three subunits each around 50 kDa. The term 11S refers to the sedimentation coefficient, with a range of 10.5–13, versus the vicilin-like globulins (7S family) with coefficients of 7.0–9.0; the 11S is characterized by a hexamer with hexagonal shape.
The predominant protein components in legume seeds are globulins (35–80%) and albumins (2–37%). Key plant sources include soybeans (where the globulins are named β-conglycinin [7S] and glycinin [11S]), peas, chickpeas, lentils, faba beans, cowpeas, adzuki beans, peanuts, and lupins. The main constituents of soy proteins are the globulins, divided into 2 types by their sedimentation coefficients: 7S or beta-conglycinin and 11S or glycinin. They constitute approximately 90% of the total protein of the seed.
Plant globulins appear in the market primarily as:
Animal-derived globulin preparations appear as:
The concept of transferring protective globulins from mother to offspring through colostrum is ancient and universal in mammalian biology. Immunoglobulins in colostrum and breast milk confer passive immunity, have anti-inflammatory properties, and contribute to the establishment of the intestinal microbiota and gut barrier integrity. Human populations throughout history have recognized the distinct properties of "first milk" — colostrum — and several traditional agricultural societies have fed colostrum of cows and other livestock to human infants and the sick as a form of nutritive and protective food.
Oral immunoglobulin (Ig) preparations are prime examples of medicinal nutrition from natural sources. Plasma products containing Ig have been used for decades in animal feed for intestinal disorders to mitigate the damaging effects of early weaning. These preparations reduce overall mortality and increase feed utilization in various animal species leading to improved growth.
It is known that antibodies may be separated from human blood and used to treat various infectious diseases. In particular, γ-globulin fractionated from blood serum has been known to have effectiveness in treatment and prophylaxis of disease and was administered by injection in the treatment of measles and other infectious diseases. This represents the historical clinical use of globulins that preceded the era of modern vaccination. It was later found that in fact, γ-globulin and part of the β-globulin fraction were composed of five major constituents: IgG, IgA, IgM, IgD and IgE, each of which has its own physiological characteristics.
Industrial-scale fractionation of globulins became possible in the 1940s with Cohn's description of preparative fractionation — an approach that employed variations in pH, ionic strength, temperature, alcohol concentration, and protein concentration. Although the original goal of Cohn's fractionation process was to obtain serum albumin to replace whole blood and plasma transfusions in the World War II battlefields, the resulting five fractions proved ideal for industrial-scale manufacturing. These plasma fractions are still used today, albeit with many modifications.
In the current climate of food security, quality aspects of legume crops have primary market economic and health impact. Legume proteins and peptides have been discovered to have a role far beyond supplying amino acids for growth and maintenance of body tissues. Across Asia, the Middle East, Latin America, and the Mediterranean, legume-based foods (tofu from soy, hummus from chickpeas, dal from lentils, falafel from fava beans) have served for millennia as primary dietary protein sources for populations with limited access to animal protein. The globulin fraction constitutes the majority of the protein in these foods, though historical users did not distinguish or characterize globulins as a category.
Alpha-1, alpha-2, and beta globulins are very similar in function, serving as enzymes which speed up and catalyze reactions, or as transport proteins which carry and escort compounds throughout the body. Specific alpha-1 functions include transport of hormones and vitamins; alpha-1 abnormalities are usually due to alpha-1 antitrypsin changes; decreases are found in congenital alpha-1-antitrypsin deficiency, and increases are found in acute inflammatory disorders, as it is an acute phase reactant. Alpha-2 abnormalities mainly involve alpha-2 macroglobulin and haptoglobin. Alpha-2 macroglobulin rises in nephrotic syndrome. Haptoglobin levels increase in stress, infection, inflammation, and tissue necrosis, and decrease with haemolytic reactions. The beta fraction consists mostly of transferrin, which is elevated in severe iron deficiency.
Alpha and beta globulins are transport proteins and serve as substrates upon which other substances are formed. Gamma globulins have a vital role in natural and acquired immunity to infection. When taken orally in the form of bovine immunoglobulin concentrates, several mechanisms have been proposed and studied:
Globulins are known to define the nutritional quality of seeds; however, they are also involved in sucrose binding, desiccation, defense against microbes, hormone binding, and oxidative stress. Globulins are a major class of seed storage proteins which were thought to be enzymatically inactive. These proteins belong to the most ancient cupin superfamily.
Legume proteins and peptides have been discovered to have a role far beyond supplying amino acids for growth and maintenance of body tissues. Several proteins (enzymatic inhibitors, lectins, storage globulins) and peptides derived from them have shown anticarcinogenic, hypocholesterolemic, glucose-lowering, antioxidant, antimicrobial, and immunostimulant properties.
For cardiovascular effects specifically, beta-conglycinin (7S globulin), a major soy storage protein, stimulates the expression of LDL receptors and the degradation of LDL by hepatocytes in vitro. One possible mechanism for the cholesterol-lowering effect was raised by Lovati et al., indicating that soy protein could modulate the levels of hepatic LDL-C receptors, suppressed in hypercholesterolemia.
This is the area with the strongest and most specific clinical evidence for oral globulin supplementation, particularly for serum-derived bovine immunoglobulin (SBI).
Randomized controlled trial — HIV-associated enteropathy: A prospective, multicenter, randomized, blinded study included a partial cross-over design comprising two study phases: a double-blind placebo-controlled phase and a placebo-free blinded extension phase. Participants were randomized to receive placebo twice daily for 4 weeks followed by either twice daily low-dose SBI (2.5 g) for 20 weeks (n=21) or high-dose SBI (5 g) for 20 weeks (n=14), or twice daily low-dose SBI for 24 weeks (n=34), or twice daily high-dose SBI for 24 weeks (n=33). SBI has been shown to improve intestinal barrier integrity and decrease inflammation in HIV-infected subjects on suppressive antiretroviral therapy with chronic diarrhea.
Ex vivo human adult model: SBI digestion and colonic fermentation were investigated using the clinically predictive ex vivo SIFR® technology (for 24 human adults). SBI (human equivalent dose [HED] = 2 and 5 g/day) significantly promoted gut barrier integrity and did so more profoundly than a dietary protein, especially upon LPS-induced inflammation. SBI also specifically lowered inflammatory markers (TNF-α and CXCL10).
Microbiome study: Serum-derived bovine immunoglobulin (SBI) is used to manage IBS and IBD and has shown prebiotic-like effects in ex vivo models. Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are chronic disorders of the gastrointestinal tract associated with gut microbiota dysbiosis and inflammation. SBI is used to manage IBS and IBD. In a small cross-sectional study, each participant served as their own control and stool samples from 18 patients with either IBS or IBD were analyzed before and after SBI administration, with relative abundance of bacterial diversity assessed using metagenomic next-generation sequencing-based profiling. The Gini-Simpson diversity index showed a significant increase post-SBI treatment (p = 0.0017), indicating a shift toward a more evenly distributed microbial community. These results suggest that supplementation with SBI positively modulates the gut microbiota.
Evidence strength: The evidence for bovine SBI in managing enteropathy — especially HIV-associated enteropathy and IBS-D — is moderate and rests on a small number of randomized trials plus mechanistic and ex vivo studies. Larger, independent replications are needed. Immune globulin bovine is a medical food used for clinical dietary management of enteropathy in patients who have a limited or impaired capacity to ingest, digest, absorb, or metabolize food or certain nutrients, and is also used to help patients manage chronic loose or frequent stools (e.g., diarrhea-predominant irritable bowel syndrome [IBS-D], HIV-associated enteropathy).
The well-established protective function of immunoglobulins in breast milk, and in neonatal health in farm animals, has meant that bovine immunoglobulins have been studied extensively for their putative effect on human health.
Randomized controlled trial — upper respiratory infections: In adults suffering from frequent upper respiratory tract infections, supplementation with a bovine IgG and lactoferrin-containing whey protein fraction (600 mg/day for 90 days) showed a reduced incidence of the common cold and cold-associated symptoms compared to the placebo group in a double-blind randomized, placebo-controlled study.
Colostrum and influenza: Decreased numbers of self-reported upper respiratory tract infections have been noted after colostrum supplementation in athletes, and colostrum prevented influenza infection in elderly volunteers comparably to influenza vaccination. Colostrum was consumed for 2 months and flu episodes were scored for 3 months.
Oral administration of Ig preparations from human serum as well as bovine colostrum and serum have been tested and proven to be safe as well as effective in human clinical trials for a variety of enteric microbial infections and other conditions which cause diarrhea.
Evidence strength: Preliminary to moderate. Most trials in this area are small, and some conflate immunoglobulins with the broader colostrum fraction (which also contains growth factors, cytokines, and other bioactives), making it difficult to attribute effects specifically to globulins alone. In a healthy, well-nourished adult, whey's main contribution remains meeting an adequate protein requirement, especially during prolonged exercise. The evidence for a direct, clinically relevant immune effect remains limited.
Animal evidence — soy 7S globulin (β-conglycinin): The aim of one study was to examine the comparative hypocholesterolemic effect of soybean 7S fraction in rats fed a high-cholesterol diet. Soybean 7S globulin (β-conglycinin) was administered orally once a day to rats, and effects were measured after 28 days. Wistar rats were divided into four groups: standard diet (casein alone), hypercholesterolemic (HC) diet, HC plus 200 mg of 7S/kg of body weight/day, and HC plus 300 mg of 7S/kg of body weight/day. Animals that had received different doses of soybean 7S globulin had lower total cholesterol, triglycerides, and LDL/HDL ratio in serum and lower levels of hepatic total cholesterol and triglycerides.
Atherosclerosis model: Mean reductions in atherosclerosis were 39% and 67% (all P <0.05) in male and ovariectomized female apoE null mice and 66% (P <0.05) in male LDL receptor null mice. These effects were unrelated to variation in isoflavone content of the protein source and only minimally related to plasma lipoprotein cholesterol concentrations. A diet rich in β-conglycinin has atheroprotective effects that greatly exceed those of isoflavone-containing soy protein isolate and do not depend on LDL receptors or influences on plasma lipoproteins.
Cowpea and adzuki bean 7S globulins: A key finding was that isolated 7S globulins from cowpea (7S-C) and adzuki bean (7S-A) are capable of reducing serum cholesterol in hypercholesterolemic rats as efficiently as simvastatin, as previously observed with rosuvastatin and β-conglycinin. These proteins increased HDL-cholesterol by 56% and 53%, respectively, while simvastatin showed a minor effect.
Evidence strength: The hypocholesterolemic and anti-atherosclerotic effects of plant 7S globulins are well-supported in animal models and in vitro. Direct human clinical trials with isolated plant globulin fractions — as distinct from whole soy protein — are sparse, and evidence in humans cannot yet be directly extrapolated from these preclinical findings.
A single daily dose of glycinin (11S soy globulin) given to the hypercholesterolemic group demonstrated its functional role, particularly in raising HDL-C and reducing triglycerides in the liver. This study demonstrates the action of the 11S globulin in soybean as a serum lipid-lowering agent, in addition to its nutritional properties, especially in raising the HDL-C.
Animal model research has also examined IgG-enriched colostrum for metabolic indications: Insulin resistance and metabolic syndrome are chronic inflammatory conditions that lead to hepatic injury and non-alcoholic steatohepatitis (NASH). Bovine colostrum has therapeutic effects in a variety of chronic infections, but its effectiveness in NASH was not previously studied. In one study, hyperimmune bovine colostrum was used to treat hepatic injury and insulin resistance, and the effects on natural killer T (NKT) cells were assessed. ob/ob mice were fed for 6 weeks with either 0.1 mg bovine colostrum prepared from non-immunized cows, 0.1 mg hyperimmune colostrum raised against a bacterial lipopolysaccharide extract, or 0.001, 0.1 or 1 mg of IgG purified from hyperimmune colostrum. This is animal data only; no equivalent human clinical trials have been published.
Plant globulins, such as legumin and vicilin, have been studied for their digestibility and potential to improve the amino acid profile of plant-based diets, making them valuable in vegetarian and vegan formulations.
7S vicilin had 6-fold higher gel strength and 5-fold higher emulsification capacity, but significantly lower nutritional quality, than 11S legumin. This reflects a functional food-science trade-off: 7S vicilins are valued for their food-processing properties, while 11S legumins provide a superior amino acid profile. The nutritional quality difference relates in part to the sulfur-containing amino acid (methionine, cysteine) content, which is higher in legumin-type globulins.
Fermentation is a traditional technique where microorganisms facilitate enzymatic reactions that reduce antinutrient content and thus increase the digestibility of plant proteins. During this process, hard-to-digest proteins like glycinin and β-conglycinin of soybean are hydrolyzed to bioactive peptides.
Evidence strength: The role of legume globulins as high-quality protein sources in human diets is well-established nutritionally. Their broader nutraceutical health claims (beyond protein nutrition) rest on preclinical and in vitro data, with insufficient human RCT evidence to make definitive clinical claims for isolated plant globulins at this time. More large-scale, controlled clinical trials are needed to fully substantiate the claimed health benefits of dietary globulins.
Dosages reported in published literature vary substantially by globulin type and application:
No universally established human clinical dosage for plant globulin fractions as isolated dietary supplements exists in the published literature as of this writing.
Serum-derived bovine immunoglobulin has self-affirmed generally recognized as safe (GRAS) status, with no objections from the FDA, and is demonstrated to be safe and well-tolerated in pediatric and adult patients.
Individuals with allergy to beef should not use bovine immunoglobulin products. No significant interactions of SBI with commonly prescribed medications have been observed. Study subjects with known beef allergies or allergies to other components of SBI should not take SBI. As with any ingested food or product, subjects who develop a hypersensitivity or food intolerance to SBI should discontinue its use.
Subjects who are pregnant or breastfeeding should not take SBI, as there are no data regarding the effects.
On oral bioavailability, a critical safety and functionality question concerns whether intact immunoglobulins survive gastrointestinal digestion. In infants, children, and adults, the amount of intact IgG recovered in stool ranges from trace amounts up to 25% of the original amount ingested. It is generally understood that IgG can only bind to antigens within the GI tract if the Fab structure is intact and has not been completely denatured through acidic pH or digestive proteolytic enzymes.
A major drawback with globulins is their tendency to bind to IgE. Both the 7S and 11S globulin families contain known food allergens. Cupin allergens include those from peanuts — Ara h 1 (7S globulin) linked to severe reactions, and Ara h 3 (11S globulin); allergens from soybean Gly m 5 (7S globulin) and Gly m 6 (11S globulin) related to severe reactions; from lentil Len c 1 (7S globulin); from lupine Lup an 1 (7S globulin); from pea Pis s 1 (7S globulin) and Pis s 2 (convicilin); from chickpea Cic a 1 (7S globulin) and Cic a 6 (11S globulin); from fenugreek Tri f 1 (7S globulin) and Tri f 3 (11S globulin); and also from tree nuts and sesame seeds.
The stability of legume globulins during gastrointestinal digestion has been reported as a major cause for their allergenicity. The vicilins, or 7S globulins, are also multimeric, digestion-resistant, seed storage molecules found in many edible plants and are frequently allergenic.
Processing affects allergenicity to different degrees: Many globulin allergens are resistant to heat. Allergenic proteins in peanut are heat-resistant, while those in soya are partially heat-stable.
When consumed as whole-food legume sources (as opposed to isolated globulin fractions), co-occurring antinutritional factors can reduce bioavailability: Legumes include numerous bioactive compounds, commonly called antinutritional factors (ANFs), because they decrease the digestibility of proteins and carbohydrates and the bioavailability of vitamins and minerals. These ANFs are proteases (trypsin, chymotrypsin, and α-amylase inhibitors), saponins, lectins, total phenolics (tannins and flavonoids), and phytic and oxalic acid.
Germination is reported to suppress the amount of phytate, tannins, and trypsin inhibitors in different legume seeds, thus improving protein digestibility. Fermentation is a traditional technique where microorganisms facilitate enzymatic reactions that reduce the antinutrient content and thus increase the digestibility of plant proteins.
Beta-lactoglobulin (BLG) is the major whey protein of cow and sheep's milk (~3 g/L) and is also present in many other mammalian species; a notable exception being humans. BLG is considered a milk allergen. BLG is thermolabile and relatively resistant to acid and enzymatic hydrolysis. Individuals with cow's milk allergy or lactose intolerance should be cautious with whey-derived immunoglobulin preparations.
The body of evidence supporting oral globulin supplementation in humans spans a wide spectrum of quality. For bovine SBI in enteropathy, a modest base of controlled clinical evidence exists, with the product holding regulatory medical food status in several countries. For plant-derived globulins as isolated nutraceutical fractions, human clinical trial data are largely absent; most relevant findings come from rodent models and in vitro mechanistic studies. More large-scale, controlled clinical trials are needed to fully substantiate the claimed health benefits of dietary globulins.
Key unresolved issues include: the degree to which intact oral immunoglobulins survive the human GI tract and remain functionally active; species differences in globulin allergenicity; whether isolated plant globulin fractions produce the same biological effects as whole legume foods; and the minimum effective doses and optimal formulations for various clinical applications.
Health conditions that Globulins may help support.
Body systems that Globulins may help support.
Go back